Eagle Pharmaceuticals
EGRX
#11127
Rank
$3.28 M
Marketcap
$0.25
Share price
0.00%
Change (1 day)
-80.00%
Change (1 year)

EPS for Eagle Pharmaceuticals (EGRX)

EPS in 2023 (TTM): $1.19

According to Eagle Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $1.19. In 2022 the company made an earnings per share (EPS) of $3.09 an increase over its 2021 EPS that were of -$0.66.

EPS history for Eagle Pharmaceuticals from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.19-61.49%
2022$3.09-568.18%
2021-$0.66
2019$1.03-52.75%
2018$2.18-36.63%
2017$3.44-35.09%
2016$5.301792.86%
2015$0.28-117.39%
2014-$1.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$6.68 461.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$5.25 341.18%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
$30.89 2,495.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$17.38 1,360.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$4.52 279.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$2.88 141.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
$0.45-62.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel